English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Background  Nonalcoholic fatty liver disease ( NAFLD ) is a major public health burden in western societies. The progressive form of NAFLD, nonalcoholic steatohepatitis ( NASH ), is characterized by hepatosteatosis, inflammation, oxidative stress, and hepatic damage that can progress to fibrosis and cirrhosis; risk factors for hepatocellular carcinoma. Given the scope of NASH, validating treatment protocols (i.e., low fat diets and weight loss) is imperative.    Methods  We evaluated the efficacy of two diets, a non-purified chow ( NP ) and purified (low-fat low-cholesterol,  LFLC ) diet to reverse western diet ( WD )-induced NASH and fibrosis in  Ldlr   -/-   mice.    Results  Mice fed WD for 22–24 weeks developed robust hepatosteatosis with mild fibrosis, while mice maintained on the WD an additional 7–8 weeks developed NASH with moderate fibrosis. Returning WD-fed mice to the NP or LFLC diets significantly reduced body weight and plasma markers of metabolic syndrome (dyslipidemia, hyperglycemia) and hepatic gene expression markers of inflammation ( Mcp1 ), oxidative stress ( Nox2 ), fibrosis ( Col1A ,  LoxL2 ,  Timp1 ) and collagen crosslinking (hydroxyproline). Time course analyses established that plasma triglycerides and hepatic  Col1A1  mRNA were rapidly reduced following the switch from the WD to the LFLC diet. However, hepatic triglyceride content and fibrosis did not return to normal levels 8 weeks after the change to the LFLC diet. Time course studies further revealed a strong association (r 2  ≥ 0.52) between plasma markers of inflammation (TLR2 activators) and hepatic fibrosis markers ( Col1A ,  Timp1 ,  LoxL2 ). Inflammation and fibrosis markers were inversely associated (r 2  ≥ 0.32) with diet-induced changes in hepatic ω3 and ω6 polyunsaturated fatty acids ( PUFA ) content.    Conclusion  These studies establish a temporal link between plasma markers of inflammation and hepatic PUFA and fibrosis. Low-fat low-cholesterol diets promote reversal of many, but not all, features associated with WD-induced NASH and fibrosis in  Ldlr   -/-   mice.

Is Western Diet-Induced Nonalcoholic Steatohepatitis in Ldlr-/- Mice Reversible?